advertisement

Topcon

Hagras SM 8

Showing records 1 to 8 | Display all abstracts from Hagras SM

95677 Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
Hagras SM
Indian Journal of Ophthalmology 2021; 69: 2475-2480
96268 Long-term outcomes of trabeculectomy with ologen implant versus combined viscotrabeculotomy-synechiolysis in uncontrolled uveitic glaucoma
Elwehidy AS; Bayoumi NHL
International Ophthalmology 2022; 42: 411-421
95677 Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
Al-Duwailah OKH
Indian Journal of Ophthalmology 2021; 69: 2475-2480
96268 Long-term outcomes of trabeculectomy with ologen implant versus combined viscotrabeculotomy-synechiolysis in uncontrolled uveitic glaucoma
Bayoumi NHL
International Ophthalmology 2022; 42: 411-421
95677 Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
Nassief MA
Indian Journal of Ophthalmology 2021; 69: 2475-2480
96268 Long-term outcomes of trabeculectomy with ologen implant versus combined viscotrabeculotomy-synechiolysis in uncontrolled uveitic glaucoma
El Nokrashy A
International Ophthalmology 2022; 42: 411-421
95677 Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
Abdelhameed AG
Indian Journal of Ophthalmology 2021; 69: 2475-2480
96268 Long-term outcomes of trabeculectomy with ologen implant versus combined viscotrabeculotomy-synechiolysis in uncontrolled uveitic glaucoma
Hagras SM
International Ophthalmology 2022; 42: 411-421

Issue 22-3

Change Issue


advertisement

Oculus